21

резултат(и)

Дума(и)
Вид публикация
Област на политиките
Автор
Ключова дума
Дата

Sexual and reproductive health rights and the implication of conscientious objection

31-10-2018

This study was commissioned by the European Parliament’s Policy Department for Citizens’ Rights and Constitutional Affairs at the request of the FEMM Committee. It aims to provide a comparative overview of the situation in the European Union, with particular focus on six selected Member States, in terms of access to sexual and reproductive healthcare goods (such as medicines) and services (such as abortion and family planning), from both legal and practical perspectives. The study looks at the extent ...

This study was commissioned by the European Parliament’s Policy Department for Citizens’ Rights and Constitutional Affairs at the request of the FEMM Committee. It aims to provide a comparative overview of the situation in the European Union, with particular focus on six selected Member States, in terms of access to sexual and reproductive healthcare goods (such as medicines) and services (such as abortion and family planning), from both legal and practical perspectives. The study looks at the extent to which conscientious objection affects access to sexual and reproductive rights (SRHR). The study will contribute to formulating a clear framework for the improvement of access to sexual and reproductive healthcare goods and services in the EU.

Външен автор

CF Consulting Services Ltd Ludovica ANEDDA, Lucy ARORA, Luca FAVERO, Nathalie MEURENS, Sophie MOREL, Martha SCHOFIELD (ICF); Senios experts: Prof Anette AGARDH (Lund University), Prof Els LEYE, independent consultant (Ghent University); National researchers: Czech Republic: Klara KOVAROVA (ICF); Croatia: Jelena MILOVANOVIC (ICF); Italy: Thomas TAYLOR-DI PIETRO, Ludovica ANEDDA (ICF); Poland: Krystyna KACPURA, Kamila FERENC (Federation for Women and Family Planning); Portugal: Dália COSTA (University of Lisbon); Sweden: Jack PALMIERI (Lund University).

Protection of workers from exposure to carcinogens or mutagens: third proposal

27-06-2018

The impact assessment (IA) accompanying the proposal for a third revision of the carcinogens and mutagens Directive 2004/37/EC clearly defines the problem to be addressed. However, it would have benefited from providing more comprehensive explanations of its evolution without EU action. The objectives appear to be relevant, sufficiently measurable, achievable, though not time-bound. The IA considers a wide range of options, and those retained for further assessment appear to be reasonable, and consistent ...

The impact assessment (IA) accompanying the proposal for a third revision of the carcinogens and mutagens Directive 2004/37/EC clearly defines the problem to be addressed. However, it would have benefited from providing more comprehensive explanations of its evolution without EU action. The objectives appear to be relevant, sufficiently measurable, achievable, though not time-bound. The IA considers a wide range of options, and those retained for further assessment appear to be reasonable, and consistent with the approach followed in two previous amendments of the directive. The analysis of impacts focuses on the economic and social dimension, mainly health, consistently with the manner in which the problem has been defined. Environmental impacts are assessed to be broadly negligible: considering that the IA is dealing with carcinogenic chemical substances, this would have perhaps required further justification. The IA acknowledges a general issue regarding, inter alia, the availability of data on the number of workers exposed, and the scarce and not always sufficiently robust epidemiological evidence. The methodological annex does not provide information regarding how the multi criteria analysis has been performed. Finally, the IA appears to have addressed most of the RSB's recommendations and the legislative proposal appears to be consistent with the analysis carried out in the IA.

What if mini-brains could help us understand dementia?

05-12-2017

Organoids are artificially grown organs that mimic the properties of real organs. What new possibilities for treating diseases, drug development, and personalised and regenerative medicine do organoids provide?

Organoids are artificially grown organs that mimic the properties of real organs. What new possibilities for treating diseases, drug development, and personalised and regenerative medicine do organoids provide?

Approval of glyphosate: Latest developments

10-11-2017

Glyphosate, one of the world's most widely used active substances in herbicides, has become the subject of controversy. A proposal by the European Commission to renew its approval for five years failed to gather a qualified majority of Member States and is to be submitted to an appeal body. The European Parliament has called for glyphosate to be phased out by 2022.

Glyphosate, one of the world's most widely used active substances in herbicides, has become the subject of controversy. A proposal by the European Commission to renew its approval for five years failed to gather a qualified majority of Member States and is to be submitted to an appeal body. The European Parliament has called for glyphosate to be phased out by 2022.

Protection of workers from exposure to carcinogens or mutagens: second proposal (CMD 2)

13-07-2017

The IA defines the problem clearly, and its evolution without EU action is comprehensively outlined. The objectives appear to be relevant, sufficiently measurable, achievable, and consistent with the manner in which the problem has been defined, as well as with other EU policies; however, they are not time-bound. The methodology used to compare the scope of impacts is well-developed, even though it is not always clear how the reported figures were obtained. However, the proposed range of options ...

The IA defines the problem clearly, and its evolution without EU action is comprehensively outlined. The objectives appear to be relevant, sufficiently measurable, achievable, and consistent with the manner in which the problem has been defined, as well as with other EU policies; however, they are not time-bound. The methodology used to compare the scope of impacts is well-developed, even though it is not always clear how the reported figures were obtained. However, the proposed range of options limits the scope of the analysis, and some of those retained for consideration are not entirely convincing. Environmental impacts are claimed not to be significant, without any explanation being provided. There is also a general issue regarding the availability of timely and reliable data, as well as the scarcity of available epidemiologic evidence. The Commission has consulted a broad range of stakeholders, and the replies received were highly representative of all national-level social partner organisations of employers and trade unions. Finally, the IA seems to have addressed the RSB's recommendations.

European Union action on cancer

02-02-2017

Cancer is a major public health concern in terms of disease burden and economic cost. Prevention and early detection are key. The European Union (EU) contributes to tackling cancer with awareness-raising, guidance, and investment in research, as well as information and coordination. This 'At a glance' note updates an earlier version of October 2015: PE 569.037.

Cancer is a major public health concern in terms of disease burden and economic cost. Prevention and early detection are key. The European Union (EU) contributes to tackling cancer with awareness-raising, guidance, and investment in research, as well as information and coordination. This 'At a glance' note updates an earlier version of October 2015: PE 569.037.

The Fight against Cancer Is a Team Sport: The Role of Education and Sport

09-12-2016

This document summarises the presentations and discussions taking place at the workshop organised by Policy Department A on the role of education and sport in the fight against cancer, held at the European Parliament in Brussels in July 2016. The aim of the workshop for the Committee on Environment, Public Health and Food Safety was to provide background information and highlight ways in which sport and physical activity can be promoted to help reduce the overall impact of cancer. Firstly the scientific ...

This document summarises the presentations and discussions taking place at the workshop organised by Policy Department A on the role of education and sport in the fight against cancer, held at the European Parliament in Brussels in July 2016. The aim of the workshop for the Committee on Environment, Public Health and Food Safety was to provide background information and highlight ways in which sport and physical activity can be promoted to help reduce the overall impact of cancer. Firstly the scientific evidence for the link between physical (in)activity and cancer was presented. Risk reductions were discussed, as well as the risks of inactivity, followed by recommendations on improving activity levels. The evidence so far is strong for colon, breast and endometrial cancers. Secondly the focus was on policy initiatives to fight against cancer through education, sport, and physical activity, with discussions on strategies and actions of the European Commission and the WHO. Finally, presentations were given by organisations set up to promote activity during or after cancer treatments, along with recommendations to prevent cancer.

Външен автор

Alojz PETERLE (MEP, EP), Michael LEITZMANN (University of Regensburg, DE), Margo MOUNTJOY (International Olympic Committee